QL
ARCT icon

Quarry LP’s Arcturus Therapeutics ARCT Stock Holding History

Quarry LP’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,296
Closed -$42.3K – 2134
2025
Q3 		$42.3K Buy
2,296
+796
+53% +$12.8K 0.01% 933
2025
Q2 		$19.5K Buy
+1,500
New +$17.7K ﹤0.01% 1195
2024
Q3 		– Sell
-45
Closed -$1.1K – 1627
2024
Q2 		$1.1K Buy
+45
New +$1.36K ﹤0.01% 1702

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Quarry LP's ARCT Position: Q4 2025 in Review

Quarry LP sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 2,296 shares — an estimated $42.3K sold.

Quarry LP first reported a position in ARCT in Q2 2024 and held it in 3 quarters. The position peaked at $42.3K in Q3 2025. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Quarry LP reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Quarry LP sold 2,296 Arcturus Therapeutics shares in Q4 2025, an estimated $42.3K.
  • Quarry LP first reported a position in Arcturus Therapeutics in Q2 2024 and held it in 3 quarters.
  • Quarry LP's Arcturus Therapeutics position peaked at $42.3K in Q3 2025.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.